Equitable Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$603K Sell
2,059
-5,790
-74% -$1.9M 0.03% 288
2025
Q4
$2.75M Sell
7,849
-162
-2% -$54.7K 0.12% 134
2025
Q3
$2.59M Buy
8,011
+68
+0.9% +$21.1K 0.12% 141
2025
Q2
$3.09M Buy
7,943
+1,491
+23% +$600K 0.15% 120
2025
Q1
$2.81M Buy
6,452
+4,391
+213% +$1.76M 0.16% 120
2024
Q4
$760K Buy
2,061
+301
+17% +$126K 0.04% 260
2024
Q3
$915K Buy
1,760
+1,082
+160% +$578K 0.06% 220
2024
Q2
$367K Buy
678
+275
+68% +$145K 0.03% 349
2024
Q1
$209K Buy
+403
New +$200K 0.01% 414
2023
Q1
Sell
-400
Closed -$205K 403
2022
Q4
$205K Buy
+400
New +$203K 0.02% 376

Other funds holding ELV

Equitable Trust's ELV Position: Q1 2026 in Review

Equitable Trust reduced its Elevance Health (ELV) stake by 74% in Q1 2026, selling an estimated $1.9M and leaving 2,059 shares worth $603K. The position accounts for 0.03% of the portfolio, ranked #288.

Equitable Trust first reported a position in ELV in Q4 2022 and has held it in 10 quarters since. The position peaked at $3.09M in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Equitable Trust held 2,059 shares of Elevance Health worth $603K as of Q1 2026.
  • Equitable Trust sold 5,790 Elevance Health shares in Q1 2026, an estimated $1.9M.
  • Elevance Health made up 0.03% of Equitable Trust's portfolio in Q1 2026, its #288 holding.
  • Equitable Trust first reported a position in Elevance Health in Q4 2022 and has held it in 10 quarters since.
  • Equitable Trust's Elevance Health position peaked at $3.09M in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.